Double-edged sword effect of biochanin to inhibit nuclear factor kappaB: Suppression of serine/threonine and tyrosine kinases

Biochemical Pharmacology

Volumn 83, Issue 10, 2012, Pages 1383-1392

  Manna, Sunil Kumar ^a  

^a CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS   (India)

Author keywords

Biochanin; IKK; NF B; Protein tyrosine kinase; PTK inhibitors; Ser Thr kinase

Indexed keywords

BIOCHANIN A; DAIDZEIN; ERBSTATIN; EXOENZYME C3; FORMONONETIN; GENISTEIN; HYDROGEN PEROXIDE; HYDROXYL GROUP; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PERVANADATE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE LCK; PROTEIN KINASE SYK; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; QUERCETIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION;

BASE SEQUENCE; GENISTEIN; HUMANS; JURKAT CELLS; NF-KAPPA B; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES;

EID: 84859106511     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.02.011     Document Type: Article

References (40)

1. M.A. Lemmon, and J. Schlessinger Cell signaling by receptor tyrosine kinases Cell 147 2010 1117 1134
2. K.D. Bosscher, W.V. Barghe, and G. Haegeman Cross-talk between nuclear receptors and nuclear factor κB Oncogene 25 2006 6868 6886
3. C. Charalambous, L.B. Pen, Y.S. Su, J. Milan, T.C. Chen, and F.M. Hofman Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells Cancer Cell 65 2005 10347 10354 (Pubitemid 41743727)
4. S.K. Manna, and G.T. Ramesh Interleukin-8 induces nuclear transcription factor-κB through TRAF6-dependent pathway J Biol Chem 280 2005 7010 7021 (Pubitemid 40341257)
5. C. Wilde, G.S. Chhatwal, G. Schmalzing, K. Aktories, and I. Just A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3 J Biol Chem 276 2001 9537 9542
6. A. Mukhopadhyay, S.K. Manna, and B.B. Aggarwal Pervanadate-induced nuclear factor-kappaB activation requires tyrosine phosphorylation and degradation of IkappaBalpha. Comparison with tumor necrosis factor-alpha J Biol Chem 275 2000 8549 8555 (Pubitemid 30180203)
7. Y. Takada, A. Mukhopadhyay, G.C. Kundu, G.H. Mahabeleshwar, S. Singh, and B.B. Aggarwal Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase J Biol Chem 278 2003 24233 24241 (Pubitemid 36830260)
8. J.Y. Chung, Y.C. Park, H. Ye, and H. Wu All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction J Cell Sci 115 2002 679 688 (Pubitemid 34196328)
9. N.P. Martin, R.P. Mohney, S. Dunn, M. Das, E. Scappini, and J.P. O'Bryan Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling Mol Pharmacol 70 2006 1643 1653
10. E. Middleton Jr., C. Kandaswami, and T.C. Theoharides The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol Rev 52 2000 673 751
11. T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, and N. Ito Genistein, a specific inhibitor of tyrosine specific protein kinases J Biol Chem 262 1987 5592 5595
12. M. Cirone, C. Zompetta, D. Tarasi, L. Frati, and A. Faggioni Infection of human T lymphoid cells by human herpesvirus 6 is blocked by two unrelated protein tyrosine kinase inhibitors, biochanin A and herbimycin AIDS Res Hum Retroviruses 12 1996 1629 1634 (Pubitemid 26423244)
13. A. Levitzki, and A. Gazit Tyrosine kinase inhibition: an approach to drug development Science 267 1995 1782 1788
14. C.Y.J. Hsu, M.V. Jacoski, M.P. Maguire, A.P. Spada, and A. Zilberstein Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue Biochem Pharmacol 43 1992 2471 2477
15. J. Park, S.H. Kim, D. Cho, and T.S. Kim Formononetin, a phytoestrogen, and its metabolites upregulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity Immunology 116 2005 71 81 (Pubitemid 41208354)
16. T.A. Mansoor, R.M. Ramalho, X. Luo, C. Ramalhete, and M.P. Cecilla Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells Phytother Res 2011 10.1002/ptr.3498
17. S.J. Su, T.M. Yeh, H.Y. Lei, and N.H. Chow The potential of soybean foods as a chemoprevention approach for human urinary tract cancer Clin Cancer Res 6 2000 230 236
18. F.G.E. Perabo, E.C. Von Low, J. Ellinger, A. Rucker, S.C. Muller, and P.J. Bastian Soy isoflavone genistein in prevention and treatment of prostate cancer Prostate Cancer Prostatic Dis 11 2008 6 12 (Pubitemid 351250324)
19. Y.J. Moon, B.S. Shin, G. An, and M.E. Morris Biochanin A inhibits breast cancer tumor growth in a murine xenograft model Pharm Res 25 2008 2158 2163
20. A.N. Lam, M. Demasi, M.J. James, A.J. Husband, and C. Walker Effect of red clover isoflavones on cox-2 activity in murine and human monocyte/macrophage cells Nutr Cancer 49 2004 89 93 (Pubitemid 39299131)
21. L. Kole, B. Giri, S.K. Manna, B. Pal, and S. Ghosh Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NF-κB nuclear translocation Eur J Pharmacol 653 2011 8 15
22. S.K. Manna, C. Gangadharan, D. Edupalli, N. Raviprakash, T. Navneetha, and S. Mahali Ras puts brake on doxorubicin-mediated cell death in p53 expressing cells J Biol Chem 286 2011 7339 7347
23. S.K. Manna, B. Babajan, P.B. Raghavendra, N. Raviprakash, and C.S. Kumar Inhibiting TNF receptor associated factor 2-mediated activation of nuclear factor kappaB facilitates induction of activator protein-1 J Biol Chem 285 2010 11617 11627
24. lck in HIV-tat versus TNF-induced cellular responses: effects on NF-κB, activator protein-1, c-Jun N-terminal kinase, and apoptosis J Immunol 164 2000 5156 5166 (Pubitemid 30305191)
25. T.L. Davis, J.R. Walker, P. Loppnau, C. Butler-Cole, A. Allali-Hassani, and S. Dhe-Paganon Autoregulation by the juxtamembrane region of the human ephrin receptor tyrosine kinase A3 (EphA3) Structure 16 2008 873 884 (Pubitemid 351778377)
26. J.H. Bae, E.D. Lew, S. Yuzawa, F. Tomé, I. Lax, and J. Schlessinger The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site Cell 138 2009 514 524
27. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, and H. Weissig The Protein Data Bank Nucleic Acids Res 28 2000 235 242 (Pubitemid 30047768)
28. E. Lindahl, B. Hess, and D. van der Spoel Gromacs 3.0: a package for molecular simulation and trajectory analysis J Mol Mod 7 2001 306 317 (Pubitemid 36153547)
29. A.W. Schuettelkopf, and D.M.F. van Aalten PRODRG a tool for high-throughput crystallography of protein-ligand complexes Acta Crystallogr 60 2004 1355 1363 (Pubitemid 41079731)
30. M.F. Guest, R.J. Harrison, J.H. van Lenthe, and L.C.H. van Corler Computational chemistry on the fps-x64 scientific computers - experience on single-processor and multiprocessor systems Theor Chim Acta 71 1987 117
31. G. Morris, R. Huey, W. Lindstrom, M. Sanner, R. Belew, and D. Goodsell AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility J Comp Chem 30 2009 2785 2791
32. K. Natarajan, S.K. Manna, M.M. Chaturvedi, and B.B. Aggarwal Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of Ikappa B alpha, nuclear translocation of p65, and subsequent gene expression Arch Biochem Biophys 352 1998 59 70 (Pubitemid 28368608)
33. M. Chiariello, J.P. Vaque, P. Crespo, and J.S. Gutkind Activation of Ras and Rho GTPases and MAP kinases by G-protein-coupled receptors Methods Mol Biol 661 2010 137 150
34. L.K. Goh, F. Huang, W. Kim, S. Gygi, and A. Sorkin Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor J Cell Biol 189 2010 871 883
35. J.A. Corbett, G. Kwon, M.H. Marino, C.P. Rodi, P.M. Sullivan, and J. Turk Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets Am J Physiol 270 1996 C1581 C1587
36. J.W. Anderson, B.M. Johnstone, and M.E. Cook-Newell Meta-analysis of the effects of soy protein intake on serum lipids N Engl J Med 333 1995 276 282
37. S.K. Manna, A. Mukhopadhyay, N.T. Van, and B.B. Aggarwal Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis J Immunol 163 1999 6800 6809
38. S.K. Manna, Y.P. Gad, A. Mukhopadhaya, and B.B. Aggarwal Suppression of tumor necrosis factor-activated nuclear transcription factor-kB, activator protein-1, c-Jun-N-terminal kinase and apoptosis by β-Lapachone Biochem Pharmacol 57 1999 763 774 (Pubitemid 29094547)
39. G.B.N. Chainy, S.K. Manna, M.M. Chaturvedi, and B.B. Aggarwal Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis Oncogene 19 2000 2943 2950 (Pubitemid 30389084)
40. S.K. Manna, N.K. Sah, R.A. Newman, A. Cisneros, and B.B. Aggarwal Oleandrin suppresses activation of nuclear transcription factor-κB, activator protein-1, and c-Jun N-terminal kinase Cancer Res 60 2000 3838 3847 (Pubitemid 32204576)